PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone
- 22 June 2005
- journal article
- Published by Wiley in FEBS Letters
- Vol. 579 (18), 4005-4011
- https://doi.org/10.1016/j.febslet.2005.06.013
Abstract
In vivo and in vitro studies have suggested a neuroprotective role for Pituitary adenylate cyclase activating polypeptide (PACAP) against neuronal insults. Here, we showed that PACAP27 protects against neurotoxicity induced by rotenone, a mitochondrial complex I inhibitor that has been implicated in the pathogenesis of Parkinson’s disease (PD). The neuroprotective effect of PACAP27 was dose-dependent and blocked by its specific receptor antagonist, PACAP6-27. The effects of PACAP27 on rotenone-induced cell death were mimicked by dibutyryl-cAMP (db-cAMP), forskolin and prevented by the PKA inhibitor H89, the ERK inhibitor PD98059 and the p38 inhibitor SB203580. PACAP27 administration blocked rotenone-induced increases in the level of caspase-3-like activity, whereas could not restore mitochondrial activity damaged by rotenone. Thus, our results demonstrate that PACAP27 has a neuroprotective role against rotenone-induced neurotoxicity in neuronal differentiated PC12 cells and the neuroprotective effects of PACAP are associated with activation of MAP kinase pathways by PKA and with inhibition of caspase-3 activity; the signaling mechanism appears to be mediated through mitochondrial-independent pathwaysKeywords
This publication has 32 references indexed in Scilit:
- Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cellsActa Pharmacologica Sinica, 2005
- Activation of mitochondrial ATP‐sensitive potassium channels increases cell viability against rotenone‐induced cell deathJournal of Neurochemistry, 2003
- The neuropeptide PACAP attenuates β-amyloid (1–42)-induced toxicity in PC12 cellsPeptides, 2002
- Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's diseaseFEBS Letters, 2001
- Basal ganglia and movement disorders: an updateTrends in Neurosciences, 1996
- Basal ganglia and movement disorders: an updateTrends in Neurosciences, 1996
- Role of mitochondria in the etiology and pathogenesis of Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Its Receptors: Neuroendocrine and Endocrine InteractionFrontiers in Neuroendocrinology, 1995
- Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)Biochemical and Biophysical Research Communications, 1990
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989